tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emily Bodnar, 221 are a BUY (84.03%), 42 are a HOLD (15.97%).
Analyst Emily Bodnar, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 26.37% that have a potential upside of 59.05% achieved within 69 days.
Emily Bodnar’s has documented 473 price targets and ratings displayed on 27 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INKT, Mink Therapeutics at 15-Jul-2025.
Analyst best performing recommendations are on NXTC (NEXTCURE ).
The best stock recommendation documented was for NXTC (NEXTCURE ) at 7/1/2025. The price target of $3 was fulfilled within 13 days with a profit of $2.56 (581.82%) receiving and performance score of 447.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$48
$0.45 (0.95%)
$48
1 years 11 months 17 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold
$56
2 years 1 months ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Hold
$48
$0.45 (0.95%)
$68
2 years 1 months 6 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$38
2 years 1 months 6 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Hold
$48
$0.45 (0.95%)
$71
2 years 1 months 6 days ago
(20-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Which stock is Emily Bodnar is most bullish on?
Which stock is Emily Bodnar is most reserved on?
What Year was the first public recommendation made by Emily Bodnar?
